Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

There were no surprises in the Bank of England’s decision to cut rates by 25 basis points to 4.5%. Although Gilts enjoyed a ...

Japan’s lower house of parliament confirmed Junko Koeda to join the Bank of Japan’s policy board, essentially ensuring she’ll ...

Japan's lower house of parliament on Friday approved the government nominee for the central bank's policy board, Junko Koeda, ...

Revenue of $11.2M and Positive Adjusted EBITDA for Seventh Consecutive QuarterStrengthened Balance Sheet and improved financial ...